Related Experiment Video
Updated: Jul 9, 2026

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
Published on: May 9, 2025
The inflammatory/fibrotic axis across organs: myelofibrosis as a model of reversibility
Lucas Greven1, Stijn Nr Fuchs2,3, Hélène Fe Gleitz1,2,3
1Institute for Cell and Tumor Biology, RWTH Aachen University Hospital, Aachen, Germany.
Abstract:
Fibrosis affects almost all organ systems, resulting in a dysfunctional extracellular matrix that impairs function and can lead to failure. Crosstalk between immune cells and the stromal environment exacerbates fibrosis in all organs and is an attractive therapeutic target. Here, we discuss recent findings regarding the cellular and molecular mechanisms that underlie inflammation and fibrosis across organs. We focus on how reciprocal immune/stromal signaling maintains fibrotic niches, outline strategies for therapeutic intervention beyond current antifibrotic agents, and highlight the bone marrow fibrotic disease myelofibrosis as a model for understanding, and ultimately reversing, fibrosis in human disease.
Related Concept Videos
Chronic Inflammation: Introduction
Cirrhosis II: Pathophysiology
Introduction to Fibroblasts
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Myocarditis I: Introduction
Inflammatory Bowel Disease III: Crohn's Disease
